| Literature DB >> 32485963 |
Hana Vylíčilová1, Magdaléna Bryksová1, Vlasta Matušková1, Karel Doležal1,2, Lucie Plíhalová1,2, Miroslav Strnad2.
Abstract
Cytokinins and their sugar or non-sugar conjugates are very active growth-promoting factors in plants, although they occur at very low concentrations. These compounds have been identified in numerous plant species. This review predominantly focuses on 9-substituted adenine-based cytokinin conjugates, both artificial and endogenous, sugar and non-sugar, and their roles in plants. Acquired information about their biological activities, interconversions, and metabolism improves understanding of their mechanisms of action and functions in planta. Although a number of 9-substituted cytokinins occur endogenously, many have also been prepared in laboratories to facilitate the clarification of their physiological roles and the determination of their biological properties. Here, we chart advances in knowledge of 9-substituted cytokinin conjugates from their discovery to current understanding and reciprocal interactions between biological properties and associated structural motifs. Current organic chemistry enables preparation of derivatives with better biological properties, such as improved anti-senescence, strong cell division stimulation, shoot forming, or more persistent stress tolerance compared to endogenous or canonical cytokinins. Many artificial cytokinin conjugates stimulate higher mass production than naturally occurring cytokinins, improve rooting, or simply have high stability or bioavailability. Thus, knowledge of the biosynthesis, metabolism, and activity of 9-substituted cytokinins in various plant species extends the scope for exploiting both natural and artificially prepared cytokinins in plant biotechnology, tissue culture, and agriculture.Entities:
Keywords: D-arabinoside; cytokinin nucleosides; cytokinin sugar conjugates; disaccharides; glucoside; meta-topolin; plant biotechnology; plant tissue culture; riboside; zeatin
Mesh:
Substances:
Year: 2020 PMID: 32485963 PMCID: PMC7356397 DOI: 10.3390/biom10060832
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Structure of naturally occurring cytokinin (CK) aminopurine derivatives. The R1 determines the type of side chain, R2-R5 specify the type of CK conjugate.
Figure 2General structure of N6-substituted adenosines and their N6-substituents [68].
Figure 3Compounds prepared and tested by Schmitz et al. in 1972 [69].
Figure 4General structures of aromatic (A) 6-benzylaminopurine-9-β-D-riboside derivatives (R1 = X, CH3, OCH3, OH, OCHF2, OCF3, CF3 or a combination of these groups), (B) 6-benzylaminopurine-9-β-L-riboside derivatives (R2 = H, F, Cl, OCH3 or OH) and (C) 6-benzylaminopurine-9-β-D-arabinoside derivatives (R3 = X, CH3, OCH3, OH, OCF3, CF3 or NH2).
Figure 5General structure of 2-chloro-6-disubstituted benzylaminopurine riboside derivatives, where R = halogens [46].
Figure 6Structure of 14-O-{3-O-[β-D-galactopyranosyl-(1→2)-α-D-galactopyranosyl-(1→3)-α- L-arabinofuranosyl]-4-O-(α-L-arabinofuranosyl)-β-D-galactopyranosyl}-trans-zeatin riboside (G3A2-ZR) [113].
Figure 7Comparison and general structures of free base, riboside and 2′-deoxyriboside derivatives, where R = X, OH, OCH3, CH3, OCF3, CF3 or a combination of these groups.
Figure 8CK disaccharides (Z9RG, DHZ9RG, iP9RG) reported by Zhang et al. (2001) and BAP9RG reported by Auer and Cohen (1993) [138,140].
Figure 9Structures of aliphatic chains substituted at the N9 atom of BAP [145].
Figure 10Structures of compounds prepared by Corse et al. (1989). On N6 (R1): tZ, cZ, DHZ, and iP side chains. On N9 (R2): 2-carboxyethyl, 2-carbo-t-butoxyethyl and 2-nitriloethyl) [146].
Figure 11Structures of Kin derivatives prepared by Mik et al. (2011) [157].
Figure 12Structures of iP derivatives prepared by Mik et al. 2011 [158].
Figure 13Structure of N9-methylated PI-55 [160].
Figure 14General structures of 9THP and 9THF ArCK derivatives (R = OH, OCH3 or their combination) [147].
Summary of substitutions at N9, N6, C2, and C8 atoms, and their combinations, that resulted in compounds with significantly higher activity than appropriate standards in indicated CK bioassays.
| Bioassay | Std. | Position of the Substituent on the Purine Ring | Ref. | |||
|---|---|---|---|---|---|---|
| N9 | N6 | C2 | C8 | |||
|
|
| β-D-ribofuranosyl- | 2-chlorobenzyl-, 3-chlorobenzyl-, | H | H | [ |
| 2-fluorobenzyl-, 3-fluorobenzyl-, | Cl | H | [ | |||
| 2′-deoxy-β-D-ribofuranosyl- | 3-hydroxybenzyl-, 2-fluorobenzyl-, 4-fluorobenzyl-, | H | H | [ | ||
| tetrahydropyran-2-yl | isopentenyl-, furfuryl- | H | 3-aminopropyl-, | [ | ||
| benzyl- | H | H | [ | |||
| tetrahydrofuran-2-yl | benzyl-, 2-methoxybenzyl-, 3-methoxybenzyl- | H | H | [ | ||
| thiofen-2-yl- | Cl | H | [ | |||
|
| tetrahydropyran-2-yl, ethoxyethyl-, 2-bromoethyl-, | isopentenyl- | H | H | [ | |
|
|
| β-D-ribofuranosyl- | 2-fluorobenzyl-, 3-fluorobenzyl-, | H | H | [ |
| 2-fluorobenzyl-, 3-fluorobenzyl-, 4-fluorobenzyl-, | Cl | H | [ | |||
| β-D-arabinofuranosyl- | benzyl-, 2-fluorobenzyl-, 3-fluorobenzyl-, | H | H | [ | ||
| 2′-deoxy-β-D-ribofuranosyl- | benzyl-, 2-hydroxybenzyl-, 3-hydroxybenzyl-, | H | H | [ | ||
| tetrahydropyran-2-yl | benzyl-, 3-hydroxybenzyl-, | H | H | [ | ||
| tetrahydrofuran-2-yl | benzyl-, 3-hydroxybenzyl- | H | H | [ | ||
| tetrahydrofuran-2-yl-, thiofen-2-yl-, | H | H | [ | |||
| tetrahydrofurfuryl- | Cl | H | [ | |||
|
| 2-bromoethyl-, 2-chloroethyl-, | furfuryl- | H | H | [ | |
|
|
| β-D-ribofuranosyl- | 2-fluorobenzyl-, 4-fluorobenzyl-, | H | H | [ |
| 2-flourobenzyl-, 3-fluorobenzyl-, 4-fluorobenzyl-, | Cl | H | [ | |||
| 2′-deoxy-β-D-ribofuranosyl- | benzyl-, 4-fluorobenzyl-, furfuryl- | H | H | [ | ||
| tetrahydropyran-2-yl | isopentenyl-, furfuryl- | H | 2-aminoethyl-, | [ | ||
| benzyl- | H | H | [ | |||
| tetrahydrofuran-2-yl | furfuryl-, thiofen-2-yl, 5-hydroxymethylfuran-2-yl- | H | H | [ | ||
| furfuryl-, tetrahydrofurfuryl-, thiofen-2-yl- | Cl | H | [ | |||
|
| ethoxyethyl-, acetoxy-, | isopentenyl- | H | H | [ | |
|
| 2-bromoethyl, 2-chloroethyl-, | furfuryl- | H | H | [ | |